1 健脾中药减少大肠癌患者化疗不良反应的系统评价
Review Articles
Chin J Evid-based Med 2009, 9(7): 802-808
系统评价
刘 静 朱 琦
上海市中医医院肿瘤科(上海 200071)
摘要 目的 评价健脾中药对大肠癌患者化疗后不良反应的改善作用。方法 计算机检索中国生物医学文献光盘数据库(CBMdisc)、中国期刊全文数据库(CJFD)、万方数据医药信息系统(Wangfang Data)和PubMed,收集化疗联合健脾中药与单纯化疗比较的随机对照试验。检索时间为1966年至2007年9月。对纳入随机对照试验进行质量评价,并采用Cochrane协作网提供的RevMan5软件进行Meta分析。结果 共纳入6个随机对照试验,包括334例患者,其中试验组188例,对照组146例,但纳入研究方法学质量均为C级。Meta分析结果显示,化疗联合健脾中药可减少I、II度白细胞降低[I度:RR=0.50,95%CI(0.31,0.80);II度:RR=0.37,95%CI(0.21,0.66)];与单纯化疗比较,II度恶心呕吐发生率差异有统计学意义[RR=0.51,95%CI(0.31,0.84)],而神经系统毒性发生率差异无统计学意义。结论 化疗与健脾中药联用可能降低大肠癌患者化疗的轻中度不良反应,如白细胞降低、恶心呕吐等,但缓解化疗药物神经毒性作用有限。由于纳入研究方法学质量不高,故此结论尚有待高质量、大样本的随机对照试验进一步证实。
关键词 健脾;化疗;大肠癌;不良反应;系统评价;随机对照试验
The Reduction of Adverse Drug Reaction Incidences of Colorectal Caner Patients Receiving Jianpi Herbs Combined with Chemotherapy: A Systematic Review
LIU Jing, ZHU Qi
Oncology Department, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, China
Abstract Objective To assess reduction of adverse drug reaction incidence in patients with colorectal cancer receiving Jianpi herbs combined with chemotherapy. Methods The randomized controlled trials (RCTs) comparing Jianpi herbs combined with chemotherapy were searched through CBMdisc, CJFD, Wangfang Data and PubMed. The search was updated to September 2007. Software RevMan5, provided by Cochrane Library, was used to perform meta-analysis. Results Six RCTs were identified in this systematic review. All the methodology quality of the enrolled RCTs was gaded C. The pooled analysis showed that Jianpi herbs combined chemotherapy significantly reduced the incidences of grade I and grade II leucopenia [grade I with RR= 0.50 and 95%CI (0.31 to 0.80); grade II with RR= 0.37 and 95%CI (0.21 to 0.66)], grade II nausea and vomiting [RR= 0.51, 95%CI (0.31 to 0.84)] compared with routine chemotherapy. There was no statistical difference in reduction of neurotoxicity between the two groups. Conclusion The methodological quality of the RCTs using Jianpi herbs combined with chemotherapy on treating colorectal cancer should be improved. Based on this systematic review, Jianpi herbs combined with chemotherapy may reduce the incidence of mild to moderate adverse drug reaction, such as leucopenia and nausea and vomiting, in patients with colorectal cancer. Well-designed RCTs are needed in the future.
Key words Jianpi; Chemotherapy; Colorectal cancer; Adverse drug reaction; Systematic review; Randomized controlled trial
大肠癌是目前我国城市居民常见的恶性肿瘤,发病率逐年上升,目前已跃居第3~5位,病死率居
作者简介:刘静,女(1971年~),副主任医师,中西医结合肿瘤学硕士、在读博士。从事中西医结合治疗胃肠道肿瘤的临床和实验研究。Email: 0651@stcmh.stnc.com
第4、5位[1,2]。中医药治疗,尤其是健脾中药的使用,作为恶性肿瘤的治疗方法之一,也已开展了广泛的临床和实验研究,同时也有研究报道中医药能降低化疗病人的不良反应(减毒作用)。本研究旨在系统评价化疗联合健脾中药与单纯化疗比较,能否降低大肠癌病人化疗中不良反应的发生。
CJEBM
802
© 2009 Editorial Board of Chin J Evid-based Med
doc.guandang.net
1_健脾中药减少大肠癌患者化疗不良反应的系统评价1_健脾中药减少大肠癌患者化疗不良反应的系统评价隐藏>> 分享到: X 分享到: 使用一键分享,轻松赚取财富值,...
1_健脾中药减少大肠癌患者... 7页 免费 1 健脾中药减少大肠癌患者... 7...本研究对健脾 中药联合静脉化疗治疗大肠癌的随机对照试验进行 Cochrane 系统评价,...
健脾中药联合化疗改善大肠癌患者免疫功能的系统评价_预防医学_医药卫生_专业资料。健脾中药联合化疗改善大肠癌患者免疫功能的系统评价DOC 格式论文,方便您的复制修改...
方案对大肠癌患者术后化疗不良反应的影响 1 2 林巧妹 , 王永辉 ( 1. 丽水... 1_健脾中药减少大肠癌患... 7页 免费 结直肠癌中医诊疗方案(试... 暂无...
目前大肠癌治疗首选方法是 手术, 但因为早期症状都是非特异性的, 许多患者治 ...本研究旨 在系统评价化疗联合健脾中药与单纯化疗比较肠癌 患者生活质量。 1? ...
暂无评价
化疗后不良反应相关性的回顾性分析徐婵媛 1, 李...方法以扶正培元为主, 充分考虑各系统各类型不良反应... 1_健脾中药减少大肠癌患... 7页 免费 二氢嘧啶...
直肠癌患者化疗期间不良反应的观察及对策_专业资料。资料与方法 本组病例137例,病理检查确诊为直肠癌,其中男86例,女51例,年龄33~74岁,平均51.1岁,所有病人...
暂无评价
78例患者随机分为2组.治疗组40例在化疗同时开始至化疗结束后1周给予健脾益气中药水煎剂口服,对照组38例单用化疗,观察2组患者近期疗效、全身副反应和生活质量评分...
热门文档